CytoMed Therapeutics Limited Ordinary Shares (GDTC)
US$ 3.45-1.43%
Price Chart
Key Statistics
Market Cap
$ 24M
P/E Ratio
0.00
Revenue (TTM)
$ 503.37K
Volume
21.12K
52W High
$ 4.05
52W Low
$ 1.20
Dividend Yield
0.00%
Beta
-0.31
Technicals
50-Day MA
2.2767
200-Day MA
2.3409
52 Week High
4.0499
52 Week Low
1.2
About GDTC
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia .
Employees
43
Headquarters
Singapore, Singapore
CEO
Mr. Chee Kong Choo
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg